TWO : 4111.TWO

Chi Sheng Pharma & Biotech Co., Ltd

$30.05 TWD

$0.1 (0.33%)

Volume
31.2K
Average Volume
98.42K
Market Capitalization
$1.8B
P/E Ratio
9.95
Dividend Yield
3.33%
Price Target
Year High
$32.90
Year Low
$28.85
Day High
—
Day Low
—
Payout Ratio
$0.32
Current Ratio
$2.26
Company Overview

TWO

Dongmao Su

Medical - Instruments & Supplies

Healthcare

4111.TWO

80

TW

TWD

https://www.cscp.com.tw

886 3 598 3811

N/A

N/A

Liquidity Metrics

0.04

2.26

2.01

1.00

0.32

Sales & Valuation

$1.38B

1.27

1.25

10.74

2.80

Profitability

$2.72

$164.28M

12.69%

15.99%

13.19%

9.21%

P/E Metrics

9.95

0.27

0.27

Analyst Price Target & Rating

Strong Buy

5/5

0 Analysts

%

Financial Health Scores

3.88

7/9

$529.36M

$1.95B

$513.11M

$209.38M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Guo Ping Xie Brand Marketing Manager
Hui-Zhen Huang Finance Manager & Accounting Supervisor
Dongmao Su Chairman & GM
Li Zhu Wei Vice President of Technology & Plant Manager
Poll Results

No votes yet today — be the first to share your view!

About Chi Sheng Pharma & Biotech Co., Ltd (TWO:4111.TWO) Stock

Chi Sheng Pharma & Biotech Co., Ltd. is a Taiwan-based company actively engaged in the development, production, distribution, and international trade of a diverse range of products. Operating across both domestic and global markets, the company specializes in pharmaceuticals, medical products, cosmetics, health foods, and medical equipment. Its extensive product portfolio covers numerous therapeutic categories, including antibiotics, chemotherapeutic agents, plasma substitutes, amino acid preparations, water nutrients, electrolyte solutions, and vitamins. Additionally, the company provides hepatotropic agents, hormones, adrenal cortical steroids, autonomic nerve agents, antihistamines, antipruritics, antipyretics, analgesics, antitussives, anti-asthmatics, gastro-intestinal preparations, a ... nd local anesthetic solutions. Further extending its offerings, Chi Sheng Pharma & Biotech supplies hemodialysis concentrates, peritoneal dialysis solutions, and various other specialized medical items. Beyond medicinal products, the company provides medical devices, fat emulsion products, anesthetics, hemostatic solutions, food products, functional beverages, skincare items, and veterinary medicines. It also offers external solutions such as those for contact lenses, saline, and iodine. The company was founded in 1962 and maintains its headquarters in Hsinchu, Taiwan.

Frequently Asked Questions

What is the current Chi Sheng Pharma & Biotech Co., Ltd (4111.TWO) stock price?

Chi Sheng Pharma & Biotech Co., Ltd(TWO:4111.TWO) stock price is $30.05 in the last trading session. During the trading session, 4111.TWO stock reached the peak price of $32.9 while $28.85 was the lowest point it dropped to. The percentage change in 4111.TWO stock occurred in the recent session was 0.33% while the dollar amount for the price change in 4111.TWO stock was $0.1.

4111.TWO's industry and sector of operation?

The TWO listed 4111.TWO is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of 4111.TWO?

Guo Ping Xie | Brand Marketing Manager
Hui-Zhen Huang | Finance Manager & Accounting Supervisor
Dongmao Su | Chairman & GM
Li Zhu Wei | Vice President of Technology & Plant Manager
|

How many employees does 4111.TWO have?

Number of 4111.TWO employees currently stands at 80. 4111.TWO operates from No. 3, Shih Chen Road, Hsinchu, None 30352, TW.

Link for 4111.TWO official website?

Official Website of 4111.TWO is: https://www.cscp.com.tw

How do I contact 4111.TWO?

4111.TWO could be contacted at phone #886 3 598 3811 and can also be accessed through its website. 4111.TWO operates from No. 3, Shih Chen Road, Hsinchu, None 30352, TW.

How many shares of 4111.TWO are traded daily?

The average number of 4111.TWO shares traded daily for last 3 months was 98.42K.

What is the market cap of 4111.TWO currently?

The market value of 4111.TWO currently stands at $1.8B with its latest stock price at $30.05